{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Houston",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "92329",
      "recalling_firm": "Revive Rx LLC dba Revive Rx Pharmacy",
      "address_1": "3831 Golf Dr Ste A",
      "address_2": "N/A",
      "postal_code": "77018-5218",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the US",
      "recall_number": "D-0771-2023",
      "product_description": "Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, NDC: 99000-9278-64.",
      "product_quantity": "45 Vials",
      "reason_for_recall": "Sub-potent Drug",
      "recall_initiation_date": "20230511",
      "center_classification_date": "20230525",
      "report_date": "20230531",
      "code_info": "Lot: 1643397 BUD: 10/16/2023"
    }
  ]
}